Literature DB >> 24141892

Synovial cytokine expression in ankle osteoarthritis depends on age and stage.

Hagen Schmal1, Ralf Henkelmann, Alexander T Mehlhorn, Kilian Reising, Gerrit Bode, Norbert P Südkamp, Philipp Niemeyer.   

Abstract

PURPOSE: Aim of the study was the analysis of cytokine expression in ankle osteoarthritis (OA) hypothesizing age-dependent regulation patterns.
METHODS: Forty-nine patients undergoing an arthroscopy of the ankle with different stages of chronic OA were prospectively included in a clinical trial comparing the group <18 years (n = 9, Ø15.1 ± 2.0 years) with the older patients (≥18 years, n = 40, Ø36.5 ± 11.9). Lavage fluids were analysed by ELISA for levels of aggrecan, BMP-2/7, IGF-1/R, bFGF, CD105, MMP-13, and IL-1β. Additionally, clinical parameters and scores (FFI, CFSS, AOFAS) were evaluated and supplemented by radiographic scores [Kellgren-Lawrence Score (KLS) for conventional X-rays, Ankle Osteoarthritis Scoring System (AOSS) for MRI].
RESULTS: In contrast to distribution of gender and BMI (p < 0.005), parameters characterizing the cartilage defect as ICRS grading, size, and duration of symptoms were not dependent on age. The incidence of osteochondritis dissecans (OCD) was higher in the group <18 years (p < 0.006), but the average degree of OCD grading was not different. KLS and AOSS were significantly higher in the group ≥18 years (p < 0.02). Correlating with the higher degree of OA in the elderly, clinical function measured by FFI and AOFAS was statistically significantly worse (p < 0.05). Intra-articular concentrations of aggrecan (3.1-fold), bFGF (8.7-fold), BMP-7 (2.7-fold), and CD105 (1.5-fold) were statistically significantly higher in the group ≥18 years (p < 0.03).
CONCLUSIONS: Confirming the hypothesis, increased synovial levels of aggrecan, bFGF, BMP-7, and CD105 were found in patients over 18 years. This correlated with a higher stage of OA determined by radiographic changes or deteriorated function and may offer starting points for new diagnostics and interventional strategies. LEVEL OF EVIDENCE: II.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24141892     DOI: 10.1007/s00167-013-2719-1

Source DB:  PubMed          Journal:  Knee Surg Sports Traumatol Arthrosc        ISSN: 0942-2056            Impact factor:   4.342


  45 in total

1.  [Differences in metabolism of chondrocytes of the knee and ankle joint].

Authors:  Wolfgang Eger; Matthias Aurich; Barbara L Schumacher; Jürgen Mollenhauer; Klaus E Kuettner; Ada A Cole
Journal:  Z Orthop Ihre Grenzgeb       Date:  2003 Jan-Feb

2.  Transchondral fractures (osteochondritis dissecans) of the talus.

Authors:  A L BERNDT; M HARTY
Journal:  J Bone Joint Surg Am       Date:  1959-09       Impact factor: 5.284

3.  Radiological assessment of osteo-arthrosis.

Authors:  J H KELLGREN; J S LAWRENCE
Journal:  Ann Rheum Dis       Date:  1957-12       Impact factor: 19.103

4.  Responsiveness and validity of the SF-36, Ankle Osteoarthritis Scale, AOFAS Ankle Hindfoot Score, and Foot Function Index in end stage ankle arthritis.

Authors:  N Jane Madeley; Kevin J Wing; Claire Topliss; Murray J Penner; Mark A Glazebrook; Alastair Se Younger
Journal:  Foot Ankle Int       Date:  2012-01       Impact factor: 2.827

5.  Cartilage and bone changes during development of post-traumatic osteoarthritis in selected LGXSM recombinant inbred mice.

Authors:  S Hashimoto; M F Rai; K L Janiszak; J M Cheverud; L J Sandell
Journal:  Osteoarthritis Cartilage       Date:  2012-02-08       Impact factor: 6.576

6.  Radiographic predictability of cartilage damage in medial ankle osteoarthritis.

Authors:  Jeong-Seok Moon; Jae-Chan Shim; Jin-Soo Suh; Woo-Chun Lee
Journal:  Clin Orthop Relat Res       Date:  2010-08       Impact factor: 4.176

7.  MRI assessment of knee osteoarthritis: Knee Osteoarthritis Scoring System (KOSS)--inter-observer and intra-observer reproducibility of a compartment-based scoring system.

Authors:  Peter R Kornaat; Ruth Y T Ceulemans; Herman M Kroon; Naghmeh Riyazi; Margreet Kloppenburg; Wayne O Carter; Thasia G Woodworth; Johan L Bloem
Journal:  Skeletal Radiol       Date:  2004-10-08       Impact factor: 2.199

8.  Synovial chondromatosis of the foot and ankle.

Authors:  Daniel D Galat; Duncan B Ackerman; Daniel Spoon; Norman S Turner; Thomas C Shives
Journal:  Foot Ankle Int       Date:  2008-03       Impact factor: 2.827

9.  Association between expression of the bone morphogenetic proteins 2 and 7 in the repair of circumscribed cartilage lesions with clinical outcome.

Authors:  Hagen Schmal; Philipp Niemeyer; Jörn Zwingmann; Fabian Stoffel; Norbert P Südkamp; Alexander T Mehlhorn
Journal:  BMC Musculoskelet Disord       Date:  2010-07-29       Impact factor: 2.362

10.  Relationship of plasma and synovial fluid BMP-7 with disease severity in knee osteoarthritis patients: a pilot study.

Authors:  Sittisak Honsawek; Maneerat Chayanupatkul; Aree Tanavalee; Manoon Sakdinakiattikoon; Benjamad Deepaisarnsakul; Pongsak Yuktanandana; Srihatach Ngarmukos
Journal:  Int Orthop       Date:  2009-03-20       Impact factor: 3.075

View more
  10 in total

1.  Prospective clinical trial of patients who underwent ankle arthroscopy with articular diseases to match clinical and radiological scores with intra-articular cytokines.

Authors:  Ralf Henkelmann; Hagen Schmal; Ingo H Pilz; Gian M Salzmann; David Dovi-Akue; Norbert P Südkamp
Journal:  Int Orthop       Date:  2015-05-07       Impact factor: 3.075

2.  Osteoarthritis in Football.

Authors:  Gian M Salzmann; Stefan Preiss; Marcy Zenobi-Wong; Laurent P Harder; Dirk Maier; Jirí Dvorák
Journal:  Cartilage       Date:  2016-07-08       Impact factor: 4.634

3.  Five-Year Outcomes After Treatment for Acute Instability of the Tibiofibular Syndesmosis Using a Suture-Button Fixation System.

Authors:  Paul F Förschner; Knut Beitzel; Andreas B Imhoff; Stefan Buchmann; Georg Feuerriegel; Felix Hofmann; Dimitrios C Karampinos; Pia Jungmann; Jonas Pogorzelski
Journal:  Orthop J Sports Med       Date:  2017-04-27

4.  RIP1 Perturbation Induces Chondrocyte Necroptosis and Promotes Osteoarthritis Pathogenesis via Targeting BMP7.

Authors:  Jin Cheng; Xiaoning Duan; Xin Fu; Yanfang Jiang; Peng Yang; Chenxi Cao; Qi Li; Jiying Zhang; Xiaoqing Hu; Xin Zhang; Yingfang Ao
Journal:  Front Cell Dev Biol       Date:  2021-04-16

5.  Biochemical characterization of early osteoarthritis in the ankle.

Authors:  Hagen Schmal; Gian M Salzmann; Elia R Langenmair; Ralf Henkelmann; Norbert P Südkamp; Philipp Niemeyer
Journal:  ScientificWorldJournal       Date:  2014-02-13

6.  Early intra-articular complement activation in ankle fractures.

Authors:  Hagen Schmal; Gian M Salzmann; Philipp Niemeyer; Elia Langenmair; Renfeng Guo; Conny Schneider; Maria Habel; Niels Riedemann
Journal:  Biomed Res Int       Date:  2014-05-21       Impact factor: 3.411

7.  Association between intraarticular cytokine levels and clinical parameters of osteochondritis dissecans in the ankle.

Authors:  Hagen Schmal; Ingo H Pilz; Ralf Henkelmann; Gian M Salzmann; Norbert P Südkamp; Philipp Niemeyer
Journal:  BMC Musculoskelet Disord       Date:  2014-05-22       Impact factor: 2.362

8.  Prospective Clinical Trial for Septic Arthritis: Cartilage Degradation and Inflammation Are Associated with Upregulation of Cartilage Metabolites.

Authors:  Hagen Schmal; Anke Bernstein; Matthias J Feucht; Benjamin Erdle; Jan M Pestka; That Minh Pham; Eva Johanna Kubosch
Journal:  Mediators Inflamm       Date:  2016-09-05       Impact factor: 4.711

9.  Validation of Activity Tracking Procedures in Elderly Patients after Operative Treatment of Proximal Femur Fractures.

Authors:  Hagen Schmal; Anders Holsgaard-Larsen; Kaywan Izadpanah; Jan Christian Brønd; Carsten Fladmose Madsen; Jens Lauritsen
Journal:  Rehabil Res Pract       Date:  2018-06-19

10.  Enhanced BMP-2/BMP-4 ratio in patients with peripheral spondyloarthritis and in cytokine- and stretch-stimulated mouse chondrocytes.

Authors:  Anne Briolay; Alaeddine El Jamal; Paul Arnolfo; Benoît Le Goff; Frédéric Blanchard; David Magne; Carole Bougault
Journal:  Arthritis Res Ther       Date:  2020-10-12       Impact factor: 5.156

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.